Optical Sensor System for Pharmaceutical Constituent Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for identifying and characterizing prescription medications are costly, unreliable, and often require trial and error, especially when variations in formulation, potency, or contamination are present, and there is no reliable way to distinguish between identical or similar medications.
Innovation Solution
A system comprising a suction mechanism, a chemical testing assembly, and a processor that analyzes data from sensors to determine the presence and concentration of active compounds or substances in a medication sample, providing a report on its identity, purity, and molecular structure.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional laboratory analysis methods are used to characterize medications, then measurement precision is improved, but cost and complexity increase significantly
Solution Approach 1:
The patent replaces complex mechanical laboratory analysis systems with an optical sensing system. The sensor detects chemical constituents through optical interactions (absorption, emission, or scattering of light), eliminating the need for complex mechanical laboratory equipment while maintaining measurement precision for identifying active compounds and contaminants.
Solution Approach 2:
The patent introduces an optical sensor as an intermediary between the medication sample and the analysis system. The sensor acts as a mediator that converts chemical information into optical signals that can be processed electronically, simplifying the overall system while maintaining analytical capability.
2Reliability
If comprehensive laboratory analysis is performed on every medication batch, then reliability is improved, but productivity decreases due to time and cost constraints
Solution Approach 1:
The patent replaces time-consuming mechanical laboratory analysis with rapid optical sensing. The sensor can analyze medication constituents in real-time or near-real-time, providing reliable batch verification without creating bottlenecks in the medication dispensing workflow.
Solution Approach 2:
The patent enables the medication itself to provide its chemical identity information through its interaction with the optical sensor. The active compounds and contaminants inherently interact with light in characteristic ways, allowing the medication to 'self-identify' without requiring extensive external analysis.
3Loss of information
If detailed chemical analysis is conducted to identify all constituents, then loss of information is reduced, but device complexity and cost increase
Solution Approach 1:
The patent employs a universal optical sensor system that can detect multiple chemical constituents simultaneously through a single measurement process. The sensor captures information about active compounds, inactive ingredients, and contaminants in one go, reducing information loss without requiring multiple specialized analysis devices.
Solution Approach 2:
The patent merges the detection of multiple chemical constituents into a single integrated optical measurement system. Rather than using separate devices for different types of analysis, the system combines multiple detection capabilities into one sensor platform, reducing complexity while maintaining comprehensive information capture.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables accurate and cost-effective characterization of prescription medications, allowing for reliable identification and differentiation between variations, reducing the risk of adverse effects and improving patient safety.
Implementation Method 1
a sensor, coupled to the intake, configured for detecting one or more constituents in the emission
Data Source
AI summary
An apparatus is disclosed comprising an intake, configured to receive an emission from a pharmaceutical, a sensor, coupled to the intake, configured for detecting one or more constituents in the emission, a processor, configured for, collecting data from the sensor regarding the one or more constituents, and analyzing the data to determine an analysis result, and a display device, coupled to the vaporizer component, configured for displaying the analysis result.